ATE256736T1 - Ein nicht-mitogener kompetitiver hgf-antagonist - Google Patents

Ein nicht-mitogener kompetitiver hgf-antagonist

Info

Publication number
ATE256736T1
ATE256736T1 AT91917603T AT91917603T ATE256736T1 AT E256736 T1 ATE256736 T1 AT E256736T1 AT 91917603 T AT91917603 T AT 91917603T AT 91917603 T AT91917603 T AT 91917603T AT E256736 T1 ATE256736 T1 AT E256736T1
Authority
AT
Austria
Prior art keywords
hgf
present
mitogenic
relates
hgf antagonist
Prior art date
Application number
AT91917603T
Other languages
English (en)
Inventor
Jeffrey S Rubin
Andrew M-L Chan
Stuart A Aaronson
Donald P Bottaro
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE256736T1 publication Critical patent/ATE256736T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91917603T 1990-09-14 1991-09-10 Ein nicht-mitogener kompetitiver hgf-antagonist ATE256736T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58206390A 1990-09-14 1990-09-14
US65550291A 1991-02-15 1991-02-15
PCT/US1991/006368 WO1992005184A1 (en) 1990-09-14 1991-09-10 A non-mitogenic competitive hgf antagonist

Publications (1)

Publication Number Publication Date
ATE256736T1 true ATE256736T1 (de) 2004-01-15

Family

ID=27078485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917603T ATE256736T1 (de) 1990-09-14 1991-09-10 Ein nicht-mitogener kompetitiver hgf-antagonist

Country Status (7)

Country Link
EP (1) EP0571387B1 (de)
JP (2) JP3438888B2 (de)
AT (1) ATE256736T1 (de)
AU (1) AU650292B2 (de)
CA (1) CA2091700C (de)
DE (1) DE69133349T2 (de)
WO (1) WO1992005184A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871959A (en) * 1989-12-27 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Method of producing hepatocycte growth factor/scatter factor and related cell lines
US6566098B1 (en) 1990-09-14 2003-05-20 The United States Of America As Represented By The Department Of Health And Human Services DNA encoding truncated hepatocyte growth factor variants
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
ATE222603T1 (de) * 1992-05-18 2002-09-15 Genentech Inc Hepatozytwachstumfaktor variante
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
WO1994003644A1 (en) * 1992-08-10 1994-02-17 Cambridge Neuroscience, Inc. Inhibitors of cell proliferation, their preparation and use
CA2144856A1 (en) * 1992-09-18 1994-03-31 Donna L. Faletto A method of preventing tumor metastasis
US6214344B1 (en) 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
US5646036A (en) * 1995-06-02 1997-07-08 Genentech, Inc. Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies
US5686292A (en) 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
KR100725199B1 (ko) 1995-08-29 2007-08-16 안제스에무지 가부시키가이샤 에이치지에프유전자를함유하는약제
US6855685B2 (en) 1995-10-24 2005-02-15 Toshikazu Nakamura Anti-cancer agent
EP0941111A4 (de) * 1996-11-05 2000-09-27 Smithkline Beecham Corp Wachstumsfaktor-antagonisten von hepatozyten
JP2003517007A (ja) * 1999-12-15 2003-05-20 エントレメッド インコーポレイテッド 内皮細胞増殖阻害組成物および方法
AU2005267720B2 (en) 2004-08-05 2012-02-23 Genentech, Inc. Humanized anti-cmet antagonists
CA2605037C (en) 2005-04-15 2015-02-24 Genentech, Inc. Hgf beta chain variants
ES2993335T3 (en) 2010-03-10 2024-12-27 Genmab As Monoclonal antibodies against c-met
BR112013030472A2 (pt) 2011-06-30 2019-09-24 Genentech Inc formulação farmacêutica, artigo de fabricação e método
BR112016021383A2 (pt) 2014-03-24 2017-10-03 Genentech Inc Método para identificar um paciente com câncer que é susceptível ou menos susceptível a responder ao tratamento com um antagonista de cmet, método para identificar um paciente apresentando câncer previamente tratado, método para determinar a expressão do biomarcador hgf, antagonista anti-c-met e seu uso, kit de diagnóstico e seu método de preparo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750197D1 (de) * 1986-04-22 1994-08-18 Salk Inst For Biological Studi Antagonisten des Fibroblasten-Wachstumsfaktors.
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons

Also Published As

Publication number Publication date
EP0571387B1 (de) 2003-12-17
AU8659591A (en) 1992-04-15
AU650292B2 (en) 1994-06-16
JP3438888B2 (ja) 2003-08-18
WO1992005184A1 (en) 1992-04-02
DE69133349D1 (de) 2004-01-29
CA2091700A1 (en) 1992-03-15
JPH06504189A (ja) 1994-05-19
JP2003102488A (ja) 2003-04-08
DE69133349T2 (de) 2004-10-07
CA2091700C (en) 2002-11-19
EP0571387A1 (de) 1993-12-01
EP0571387A4 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
DE69133349D1 (de) Ein nicht-mitogener kompetitiver hgf-antagonist
NO953462L (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
ATE114169T1 (de) Morphogenetisches knochenprotein.
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
ATE249219T1 (de) Antivirale verbindungen
PT839196E (pt) Ctla-8 humana e utilizacoes de proteinas relacionadas com ctla-8
DE69008155D1 (de) Herstellung von Stoffliesen.
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
ATE179991T1 (de) N-terminal chemisch modifizierte protein- zusammensetzungen und methoden
ATE259420T1 (de) Mutanten des keratinocyten-wachstumsfaktor-2 (kgf-2 oder fibroblastenwachstumsfaktor-12,fgf-12)
NO930599D0 (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
FI885807L (fi) Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
DK198490D0 (da) Heterocykliske forbindelser, deres fremstilling og anvendelse
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
ATE403726T1 (de) Cytokin-proteinfamilie
DK462687A (da) Forbindelse til behandling af retrovirusinfektioner.
DE69034076D1 (de) Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2169124T3 (es) Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.
ES2054633T3 (es) Uso del probucol para la prevencion y el tratamiento de las enfermedades cardiacas.
IT1202565B (it) Purificazione di interleuchina-1 umana ricombinante
TR199800705T2 (de)
NO923646D0 (no) Azacykliske eller azabicykliske forbindelser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties